Rob Capone
InvestorPartner at Telegraph Hill Partners · Board director at Panome Bio · Board director at Mosaicbio
Chapel Hill, North Carolina
Writes $100K – $5M checks · typically $1.5M
About
Rob Capone is a Partner at THP who previously spent four years at Telegraph Hill Partners as an Associate before working ten years as a strategy consultant, most recently as a Partner at Trinity Life Sciences. He serves on the boards of Cell Microsystems and Emerging Therapy Solutions and holds a BBA from Notre Dame and an MBA from UC Berkeley's Haas School.
Contact· self-published, not guessed
Invests in
BiotechMedical Devices
Board director at Panome Bio
Intro paths
In turn, Rob can intro founders to Panome Bio's investors below.
Panome Bio's investors · 3
Co-founders at Panome Bio


Board director at Mosaicbio
Intro paths
In turn, Rob can intro founders to Mosaicbio's investors below.
Mosaicbio's investors · 1
Co-founders at Mosaicbio
Experience
- Telegraph Hill PartnersPartnercurrent2021 — presentRaleigh-Durham-Chapel Hill Area
- TRINITYPartner2020 — 2021Raleigh-Durham-Chapel Hill Area
- BluePrint Research GroupPartner2017 — 2020San Francisco, California
- BluePrint Research GroupAssociate Partner2015 — 2017San Francisco Bay Area
- ZS AssociatesEngagement Manager2013 — 2015San Francisco Bay Area
- ZS AssociatesConsultant2011 — 2013San Francisco Bay Area
- ZS AssociatesSummer Associate2010
- Telegraph Hill PartnersAssociate2006 — 2009San Francisco Bay Area
- Seven Hills PartnersAnalyst2004 — 2006San Francisco Bay Area
Deals · 2
Emerging Therapy SolutionsBoard seat
via Telegraph Hill Partners · filed Dec 2022
Cell MicrosystemsBoard seat
via Telegraph Hill Partners · filed Nov 2021 · $12.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Sources: the firm's website · SEC Form D filings.
Colleagues at Telegraph Hill Partners
Network3
Investors connected to Rob in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Rob Capone?
- Rob Capone is a Partner at THP who previously spent four years at Telegraph Hill Partners as an Associate before working ten years as a strategy consultant, most recently as a Partner at Trinity Life Sciences. He serves on the boards of Cell Microsystems and Emerging Therapy Solutions and holds a BBA from Notre Dame and an MBA from UC Berkeley's Haas School.
- Where does Rob Capone work?
- Rob Capone is Partner at Telegraph Hill Partners and Board director at Panome Bio and Board director at Mosaicbio.
- What does Rob Capone invest in?
- Rob Capone invests in Biotech, Medical Devices.
- What check size does Rob Capone write?
- Rob Capone typically writes checks of $100K – $5M.
- What boards does Rob Capone sit on?
- Rob Capone holds tracked board seats at Cell Microsystems, Cell Microsystems, Emerging Therapy Solutions, Emerging Therapy Solutions, Mosaicbio, Panome Bio.
- Where did Rob Capone go to school?
- Rob Capone studied at University of California, Berkeley, Haas School of Business (Master of Business Administration); University of Notre Dame (BBA, Finance).
Same school
Also attended University of California, Berkeley, Haas School of Business616
+ 610 more
Shared employers
Also worked at TRINITY10
+ 4 more
Also worked at BluePrint Research Group2
Also worked at ZS Associates46
+ 40 more
Also worked at Telegraph Hill Partners11
+ 5 more











































